期刊文献+

多发性骨髓瘤并发外周神经病变病人的综合护理 被引量:1

Comprehensive nursing care of multiple myeloma patients complicated with peripheral neuropathy
下载PDF
导出
摘要 [目的]探讨多发性骨髓瘤并发外周神经病变的疗效及护理。[方法]选择2010年12月—2013年12月在我院住院多发性骨髓瘤病人58例为干预组,2010年12月前在我院住院多发性骨髓瘤病人52例为对照组。对照组采用常规护理,干预组在对照组的基础上重视全面评估,及时给予心理护理,指导康复训练,重视出院准备及出院后延伸护理。比较两组病人外周神经病变发生率、病变发生程度及对护理工作的满意度。[结果]干预组病人外周神经病变总发生率明显低于对照组(P<0.05);干预组病人对护理工作的满意度明显高于对照组(P<0.05)。[结论]对多发性骨髓瘤病人实施综合护理干预,有助于降低外周神经病变发生率,减轻病变发生程度,提高病人对护理工作的满意度。
作者 徐任菊 傅荣
出处 《护理研究(下旬版)》 2014年第9期3363-3364,共2页 Chinese Nursing Researsh
基金 江苏省2010年国家临床重点专科建设项目
  • 相关文献

参考文献3

  • 1陈丽娟.老年多发性骨髓瘤周围神经病变防治[J].实用老年医学,2013,27(9):719-722. 被引量:4
  • 2黄梅,周剑峰.多发性骨髓瘤治疗新药及新的治疗策略[J].临床内科杂志,2007,24(9):587-589. 被引量:3
  • 3Philippe Moreau,Halyna Pylypenko,Sebastian Grosicki,Ievgenii Karamanesht,Xavier Leleu,Maria Grishunina,Grigoriy Rekhtman,Zvenyslava Masliak,Tadeusz Robak,Anna Shubina,Bertrand Arnulf,Martin Kropff,James Cavet,Dixie-Lee Esseltine,Huaibao Feng,Suzette Girgis,Helgi van de Velde,William Deraedt,Jean-Luc Harousseau.Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study[J].Lancet Oncology.2011(5)

二级参考文献21

  • 1Benedetto Bruno,Marcello Rotta,Francesca Patriarca,et al.A Comparison of Allografting with Autografting for newly Diagnosed myeloma.The New Engl J of Med,2007,356:1110-1120.
  • 2Palumbo A,Bertola A,Musto P,et al.Oral Melphalan,prednisone and thalidomide for newly diagnosed patients with myeloma.Cancer,2005,104:1428-1433.
  • 3Palumbo A,Bringhen S,Caravita T,et al.Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma:randomised controlled trial.The Lancet,2006,367:825-831.
  • 4Palumbo A,Falco P,Benevolo G,et al.Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.J Clin Oncol,2006,24 (pt 1 suppl 18S):426s.
  • 5Mateos MV,Hernandez JM,Hernandez MT,et al.Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:results of a multicenter phase Ⅰ/Ⅱ study.Blood,2006,108:2165-2172.
  • 6Hussein MA,Baz R,Srkalovic G,et al.Phase 2 study of pegyleted liposomal doxorubicin,vincristine,decreased-frequency dexamethasone and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.Mayo Clin Proc,2006,81:889-895.
  • 7Jackson DY,Case LD,Pope EK,et al.Single agent vincristine by infusion in refractory multiple myeloma.J Clin Oncol,1985,3:1508-1512.
  • 8Moreau P,Facon T,Attal M,et al.Intergroupe Francophone du myelome.Comparison of 200mg/m2 melphalan and 8 GY total body irradiation plus 140mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma:final analysis of the Intergroupe Francophone du myeloma 9502 randomized trial.Blood,2002,99:731-735.
  • 9Child J,Morgan G,Davies F,et al.High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.N Engl J Med,2003,348:1875-1883.
  • 10Bensinger W,Maloney D,Storb R.Allogeneic hematopoietic cell trans-plantation for multiple myeloma.Semin Hematol,2001,38:243-249.

共引文献5

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部